GE Medical absorbs small CIS firm

Article

GE Medical Systems Information Technologies has purchased SEC, a developer of enterprise-wide clinical information systems. Terms of the deal were not disclosed. SEC's suite of CIS software applies client-server and Internet-based

GE Medical Systems Information Technologies has purchased SEC, a developer of enterprise-wide clinical information systems. Terms of the deal were not disclosed. SEC's suite of CIS software applies client-server and Internet-based architecture to enable efficient point-of-care clinical work processes and provide a single, comprehensive clinical data repository. Vik Kheterpal, formerly president and CEO of SEC, is now general manager of CIS for GE.

In a related development, Sentillion's Vergence Context Management software will be integrated into GE's QS clinical information system for use in perinatal and critical care applications. GE is using Vergence software development tools to enhance QS with the HL7 CCOW standard, which defines the basis for creating a cooperative, multivendor clinical desktop.


© 2000 Miller Freeman Inc.
11/29/00, Issue # 117, page 5.

Recent Videos
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Can AI Assessment of Longitudinal MRI Scans Improve Prediction for Pediatric Glioma Recurrence?
A Closer Look at MRI-Guided Adaptive Radiotherapy for Monitoring and Treating Glioblastomas
Incorporating CT Colonography into Radiology Practice
What New Research Reveals About Computed Tomography and Radiation-Induced Cancer Risk
What New Interventional Radiology Research Reveals About Treatment for Breast Cancer Liver Metastases
New Mammography Studies Assess Image-Based AI Risk Models and Breast Arterial Calcification Detection
Can Deep Learning Provide a CT-Less Alternative for Attenuation Compensation with SPECT MPI?
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Related Content
© 2025 MJH Life Sciences

All rights reserved.